Abstract
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death and is on the increase worldwide. Hepatocellular carcinoma results from chronic liver disease and cirrhosis most commonly associated with chronic hepatitis B (HBV) or hepatitis C (HCV) infection. The highest incidences of HCC are found in China and Africa, where chronic HBV infection is the major risk component. In the United States, Europe and Japan, the significant increase in HCC and HCC-related deaths within the last three decades is mainly attributed to the rise in the number of HCV-infected individuals; smaller increases of HCC are associated with HBV. Given that HCV and HBV infection account for the majority of HCCs, therapeutic and prophylactic approaches to control or eliminate virus infection may prove effective in reducing the occurrence of HCC. Although anti-viral therapies exist for both HBV and HCV infections, they are ineffective for a significant number of patients. In addition, some treatments such as interferon therapy are dose limiting owing to toxic side effects. Clearly, new approaches are needed. RNA interference (RNAi)-based approaches may meet this need and have already shown promising preclinical results in cell culture and animal models. Although this paper focuses on the potential of RNAi as a prophylactic for HCC development, the potential use of RNAi-mediated approaches for HCC therapy will also be discussed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bartenschlager R, Lohmann V . (2000). J Gen Virol 81: 1631–1648.
Blanc JF, Lalanne C, Plomion C, Schmitter JM, Bathany K, Gion JM et al. (2005). Proteomics 5: 3778–3789.
Blight KJ, Kolykhalov AA, Rice CM . (2000). Science 290: 1972–1974.
Blight KJ, McKeating JA, Rice CM . (2002). J Virol 76: 13001–13014.
Bukh J, Miller RH, Purcell RH . (1995). Semin Liver Dis 15: 41–63.
Cai Z, Zhang C, Chang KS, Jiang J, Ahn BC, Wakita T et al. (2005). J Virol 79: 13963–13973.
Chayama K, Tsubota A, Arase Y, Saitoh S, Ikeda K, Matsumoto T et al. (1995). J Hepatol 23: 648–653.
Chen M, Sallberg M, Hughes J, Jones J, Guidotti LG, Chisari FV et al. (2005). J Virol 79: 3016–3027.
Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C et al. (1995). J Clin Invest 96: 224–230.
Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC . (1998). Nature 391: 806–811.
Giladi H, Ketzinel-Gilad M, Rivkin L, Felig Y, Nussbaum O, Galun E . (2003). Mol Ther 8: 769–776.
Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R . (2005). Cell 123: 6313–6640.
Guo Y, Guo H, Zhang L, Xie H, Zhao X, Wang F et al. (2005). J Virol 79: 14392–14403.
Hamasaki K, Nakao K, Matsumoto K, Ichikawa T, Ishikawa H et al. (2003). FEBS Lett 543: 51–54.
Hamilton AJ, Baulcombe DC . (1999). Science 286: 950–952.
Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ . (2001). Science 293: 1146–1150.
Hisaka T, Yano H, Haramaki M, Utsunomiya I, Kojiro M . (1999). Int J Oncol 14: 453–460.
Huang ZM, Yen TS . (1993). J Virol 67: 7032–7040.
Ito Y, Sasaki Y, Horimoto M, Wada S, Tanaka Y, Kasahara A et al. (1998). Hepatology 27: 951–958.
Kapadia SB, Brideau-Andersen A, Chisari FV . (2003). Proc Natl Acad Sci USA 100: 2014–2018.
Kawabata K, Takakura Y, Hashida M . (1995). Pharm Res 12: 825–830.
Klein C, Bock CT, Wedemeyer H, Wustefeld T, Locarnini S, Dienes HP et al. (2003). Gastroenterology 125: 9–18.
Korf M, Jarczak D, Beger C, Manns MP, Kruger M . (2005). J Hepatol 43: 225–234.
Krönke J, Kittler R, Buchholz F, Windisch MP, Peitschmann T, Bartenschlager R et al. (2004). J Virol 78: 3436–3446.
Kruger M, Berger C, Welch PJ, Barber JR, Manns MP, Wong-Staal F. (2001). Mol Cell Biol 21: 8357–8364.
Lau DT, Khokhar MF, Doo E, Ghany MG, Herion D, Park Y et al. (2000). Hepatology 32: 828–834.
Lau NC, Lim LP, Weinstein EG, Bartel DP. (2001). Science 294: 858–862.
Leonard JN, Schaffer DV . (2005). Gene Ther 13: 532–540.
Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC et al. (2005). Science 309: 623–626.
Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R . (1999). Science 285: 110–113.
Lohmann V, Roos A, Korner F, Koch JO, Bartenschlager R . (2000). J Viral Hepatol 7: 167–174.
Lui F, Song Y, Lui D . (1999). Gene Ther 6: 1258–1266.
Mao HJ, Li HN, Zhou ZM, Zhao JL, Wan DF . (2005). World J Gastroenterol 11: 2811–2816.
Matranga C, Tomari Y, Shin C, Bartel D, Zamore PD . (2005). Cell 123: 607–620.
McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, Kay MA . (2002). Nature 418: 38–39.
McCaffrey AP, Nakai H, Pandey K, Huang Z, Salazar FH, Xu H et al. (2003). Nat Biotechnol 21: 634–639.
Mendy ME, Fortuin M, Hall AJ, Jack AD, Whittle HC . (1999). Br J Biomed Sci 56: 34–38.
Miura H, Miyazaki T, Kuroda M, Oka T, Machinami R, Kodama T et al. (1997). J Hepatol 27: 854–861.
Morrissey DV, Blanchard K, Shaw L, Jensen K, Lockridge JA, Dickenson B et al. (2005a). Hepatology 41: 1349–1356.
Morrissey DV, Lockridge JA, Shaw L, Blanchard K, Jensen K, Breen W et al. (2005b). Nat Biotechnol 23: 1002–1007.
Papatheodoridis GV, Dimou E, Papadimitropoulos V . (2002). Am J Gastroenterology 97: 1618–1628.
Prabhu R, Vittal P, Yin Q, Flemington E, Garry R, Robichaux WH et al. (2005). J Med Virol 76: 511–519.
Radhakrishnan SK, Layden TJ, Gartel AL . (2004). Virology 323: 173–181.
Rand TA, Petersen S, Du F, Wang X . (2005). Cell 123: 621–629.
Randall G, Grakoui A, Rice CM . (2003). Proc Natl Acad Sci USA 100: 235–240.
Ren GL, Bai XF, Zhang Y, Chen HM, Huang CX, Wang PZ et al. (2005). Biochem Biophys Res Commun 335: 1051–1059.
Schmidt CM, McKillop JH, Cahill PA, Sitzmann JV . (1997). Biochem Biophys Res Commun 236: 54–58.
Shlomai A, Shaul Y . (2003). Hepatology 37: 764–770.
Simmonds P . (1999). J Hepatology 31: 54–60.
Song E, Lee SK, Wang J, Ince N, Ouyang N, Min J et al. (2003). Nat Med 9: 347–351.
Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M et al. (2004). Nature 432: 173–178.
Spangberg K, Wiklund L, Schwartz S . (2000). Virology 274: 378–390.
Suzuki K, Hayashi N, Miyamoto Y, Yanamoto M, Ohkawa K, Ito Y et al. (1996). Cancer Res 56: 3004–3009.
Uprichard SL, Boyd B, Althage A, Chisari FV . (2005). Proc Natl Acad Sci USA 102: 773–778.
Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z et al. (2005). Nat Med 11: 791–796.
Wilson JA, Richardson CD . (2005). J Virol 79: 7050–7058.
Wilson JA, Jayasena S, Khvorova A, Sabatinos S, Rodrigue-Gervais IG, Arya S et al. (2003). Proc Natl Acad Sci USA 100: 2783–2788.
Wong N, Chan KYY, Macgregor PF, Lai PBS, Squire JA, Beheshti B et al. (2005). Clin Cancer Res 11: 1319–1326.
Wu HL, Huang LR, Huang CC, Lai HL, Liu CJ, Huang YT et al. (2005). Gastroenterology 128: 708–716.
Ying C, De Clercq E, Neyts J . (2003). Biochem Biophys Res Commun 309: 482–484.
Yang PL, Althage A, Chung J, Chisari FV. (2002). Proc Natl Acad Sci USA 99: 12825–13830.
Yokota T, Sakamoto N, Enomoto N, Tanabe Y, Miyagishi M, Maekawa S et al. (2003). EMBO Rep 4: 602–608.
Zamore PD, Tuschl T, Sharp PA, Bartel DP . (2000). Cell 101: 25–33.
Zhang G, Gao X, Song YK, Vollmer R, Stolz DB, Gasiorowski JZ et al. (2004a). Gene Ther 11: 675–682.
Zhang XN, Xiong W, Wang JD, Hu YW, Xiang L, Yuan ZH . (2004b). World J Gastroenterol 10: 2967–2971.
Zhong J, Gastaminza P, Cheng G, Kapakia S, Kato T, Burton DR et al. (2005). Proc Natl Acad Sci USA 102: 9294–9299.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Romano, P., McCallus, D. & Pachuk, C. RNA interference-mediated prevention and therapy for hepatocellular carcinoma. Oncogene 25, 3857–3865 (2006). https://doi.org/10.1038/sj.onc.1209549
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1209549
Keywords
This article is cited by
-
The Role of Small Interfering RNAs in Hepatocellular Carcinoma
Journal of Gastrointestinal Cancer (2023)
-
Hepatocellular carcinoma: insight from animal models
Nature Reviews Gastroenterology & Hepatology (2012)
-
Knockdown of HBx by RNAi inhibits proliferation and enhances chemotherapy-induced apoptosis in hepatocellular carcinoma cells
Medical Oncology (2010)
-
Gene silencing of MAT1 mediated by siRNA inhibits cell proliferation and invasion in pancreatic cancer in vitro
The Chinese-German Journal of Clinical Oncology (2008)
-
Hepatocarcinoma: from pathogenic mechanisms to target therapy
Oncology Reviews (2008)